| 2 | Cross Kingdom Activators of Five Classes of Bacterial Effectors. (Anderson DM, Feix JB, Frank DW) PLoS Pathog 2015 Jul;11(7):e1004944 11 Citations |
| 1 | Regulatory polymorphisms and their contribution to interindividual differences in the expression of enzymes influencing drug and toxicant disposition. (Hines RN, Koukouritaki SB, Poch MT, Stephens MC) Drug Metab Rev 2008;40(2):263-301 18 Citations |
| 1 | Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea. (Kurpad SN, Dolan ME, McLendon RE, Archer GE, Moschel RC, Pegg AE, Bigner DD, Friedman HS) Cancer Chemother Pharmacol 1997;39(4):307-16 30 Citations |
| 1 | Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli. (Noriega FR, Losonsky G, Wang JY, Formal SB, Levine MM) Infect Immun 1996 Jan;64(1):23-7 71 Citations |
| 1 | Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan. (Friedman HS, Dolan ME, Kaufmann SH, Colvin OM, Griffith OW, Moschel RC, Schold SC, Bigner DD, Ali-Osman F) Cancer Res 1994 Jul 01;54(13):3487-93 54 Citations |
© 2026 Clinical & Translational Science Institute